Ethacrynic Acid

Authors

Chade Aribo, University of California RiversideFollow
Daniel Ng

Division

Far West

Hospital

Riverside Community Hospital

Document Type

Review Article

Publication Date

6-9-2020

Keywords

diuretics, edema, heart failure, renal insufficiency

Disciplines

Cardiology | Chemicals and Drugs | Emergency Medicine | Organic Chemicals

Abstract

Excerpt

Ethacrynic acid is a loop diuretic that gained FDA approval for widespread use in 1967. Unlike other loop diuretics, ethacrynic acid is a novel drug due to the absence of a sulfonamide group in its structure, allowing its use in critically ill patients with life-threatening sulfa-allergies.[1] In adults, ethacrynic acid is a choice for the relief of edema in patients with renal failure, congestive heart failure, and cirrhotic ascites in the setting of sulfonamide hypersensitivity and treatment-resistant pathologies.

Publisher or Conference

StatPearls

Recommended Citation

Aribo C, Ng DK. Ethacrynic Acid. [Updated 2020 Jun 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558988/